Clinical Trials
2 trialsNCT00226993 2016-12-01
Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Stanford University
Phase 1/2 Withdrawn
NCT00185965 2014-08-01
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Stanford University
Phase 1/2 Completed